Considerations to accelerating and maximize the preclinical studies to a safe and effective COVID-19 vaccine
<p>The emergence of novel coronavirus-2019 (COVID-19) by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus and its rapid spread across the world have triggered a global health emergency without preceding. From the first report of COVID-19 at Wuhan city of China in December 201...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Journal of Vaccines and Immunology - Peertechz Publications,
2021-01-25.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |